Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement ; volume:11 ; number:1 ; day:9 ; month:7 ; year:2011 ; pages:1-8 ; date:12.2011
BMC cancer ; 11, Heft 1 (9.7.2011), 1-8, 12.2011
- Creator
-
Tse, Vicki C.
- Contributor
-
Ng, Wai Tong
Lee, Victor
Lee, Anne WM
Chua, Daniel TT
Chau, June
McGhee, Sarah M.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-11-288
- URN
-
urn:nbn:de:1111-2016030366375
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tse, Vicki C.
- Ng, Wai Tong
- Lee, Victor
- Lee, Anne WM
- Chua, Daniel TT
- Chau, June
- McGhee, Sarah M.
- SpringerLink (Online service)
Other Objects (12)
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
Optimal cost reimbursement of health insurers to reduce risk selection
Optimal cost reimbursement of health insurers to reduce risk selection
Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
The Oesophageal Cancer Multidisciplinary Team: Can Machine Learning Assist Decision-Making?
Artificial intelligence to assist decision-making on pharmacotherapy: A feasibility study
MISSION FIELD REIMBURSEMENT FILE
Cost-effectiveness of long term left ventricular assist devices
Cost-effectiveness and algorithmic decision-making
Machine learning to assist clinical decision-making during the COVID-19 pandemic
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
Optimal cost reimbursement of health insurers to reduce risk selection
Optimal cost reimbursement of health insurers to reduce risk selection
Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
The Oesophageal Cancer Multidisciplinary Team: Can Machine Learning Assist Decision-Making?
Artificial intelligence to assist decision-making on pharmacotherapy: A feasibility study
MISSION FIELD REIMBURSEMENT FILE
Cost-effectiveness of long term left ventricular assist devices
Cost-effectiveness and algorithmic decision-making
Machine learning to assist clinical decision-making during the COVID-19 pandemic
How is Clinical Trial Reimbursement Money Spent? South African Trial Participants’ Reported Reimbursement Spending Patterns and Perceptions of Appropriate Reimbursement Amounts
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
Optimal cost reimbursement of health insurers to reduce risk selection
Optimal cost reimbursement of health insurers to reduce risk selection
Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
The Oesophageal Cancer Multidisciplinary Team: Can Machine Learning Assist Decision-Making?
Artificial intelligence to assist decision-making on pharmacotherapy: A feasibility study
MISSION FIELD REIMBURSEMENT FILE
Cost-effectiveness of long term left ventricular assist devices
Cost-effectiveness and algorithmic decision-making
Machine learning to assist clinical decision-making during the COVID-19 pandemic